A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma

NCT00667342 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Osteosarcoma
Malignant Fibrous Histiocytoma (MFH) of Bone

Interventions

BIOLOGICAL: Bevacizumab
DRUG: Cisplatin
DRUG: Doxorubicin
DRUG: Methotrexate
DRUG: Ifosfamide
DRUG: etoposide
PROCEDURE: Surgery
RADIATION: Radiotherapy

Sponsor

St. Jude Children's Research Hospital

Collaborators

[object Object]